Citadel Advisors’s M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 MBAC.WS Stock Holding History

Citadel Advisors's MBAC.WS Position: Q4 2023 in Review

Citadel Advisors sold out of M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (MBAC.WS) in Q4 2023, closing a stake of 447,682 shares — an estimated $20.4K sold.

Citadel Advisors first reported a position in MBAC.WS in Q2 2021 and held it in 9 quarters. The position peaked at $655K in Q1 2022. 1 fund tracked by Wall St. Rank holds MBAC.WS as of Q4 2023.

• Citadel Advisors reported no remaining M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
• Citadel Advisors sold 447,682 M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q4 2023, an estimated $20.4K.
• Citadel Advisors first reported a position in M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q2 2021 and held it in 9 quarters.
• Citadel Advisors's M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $655K in Q1 2022.
• 1 fund tracked by Wall St. Rank held M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.